| Organisation | Aurora Fine Chemicals Ltd. |
|---|---|
| ZIP - City, Country | A-8020 - Graz (Austria) |
| Street | Reininghausstrasse 49 |
| Phone | +43 316 58 67 38 |
| aurora@aurorafinechemicals.com | |
| www | aurorafinechemicals.com |
| Organisation | Company |
| Participant | |
![]() | Dr. Alexander Kutyrev manager Languages: German  English   Available for B2B meetings: Yes |
| Company (Organisation) details | |
|---|---|
| RESEARCH ACTIVITIES: Using Aurora Fine Chemicals Ltd. a drug discovery service, compound libraries, focused libraries and focused library design and a custom synthesis to support your companys research programs can help you to atchieve your goals in pharmaceutical development. INTERNATIONAL EXPERTISE IN RTD: Established company in the field of drug discovery service, see http://www.aurorafinechemicals.com/services.html. | |
| Type of co-operation | - RTD-cooperation ( Both ) |
| Areas of activity: | - Biochemistry and Biophysics - Bioinformatics - Pharmacology - Others |
| Profile No.1 (Partnership (Offered)) | |
|---|---|
| Title | From biological target to drug molecules. |
| Description | DESCRIPTION OF EXPERTISE OFFERED: Aurora provides services that help you to maximize the value of your research and development. Our goal is to create unique service experience for every customer by listening to your requirements and responding to them with innovative initiatives. Monitoring our performance against world-class service standards as well as support every client with the Auroras portfolio of services and products belong to our most important tasks. INNOVATIVE RTD ASPECT: Why do you even need Aurora for your pharmaceutical development? Because firstly, there’s a complete solution for drug candidates – you just need to show your biological target and the complete process for looking for drug molecules will be done for you. Secondly, Aurora is using its unique software, based on direct models, created by quantum mechanical analysis of molecular interactions and thermodynamics. As a result, the prediction capability of models is better in comparison to a QSAR method that doesn’t work for absolutely novel compounds. DESCRIPTION OF REQUESTED PARTNER PROFILE: Companies, universities, institutes, medical and research organizations that are looking for a complete solution for drug candidates. Any organizations that are looking for a distribution of their life science services in Europe, North America and Japan. OTHER SPECIFIC RTD ASPECTS NEEDED: |
| Entry/Update: | 2007-09-28 / 2007-09-28 |